Tyzoon Nomanbhoy

4.2k total citations · 1 hit paper
47 papers, 3.3k citations indexed

About

Tyzoon Nomanbhoy is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Tyzoon Nomanbhoy has authored 47 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Tyzoon Nomanbhoy's work include Protein Kinase Regulation and GTPase Signaling (9 papers), RNA and protein synthesis mechanisms (7 papers) and RNA modifications and cancer (7 papers). Tyzoon Nomanbhoy is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), RNA and protein synthesis mechanisms (7 papers) and RNA modifications and cancer (7 papers). Tyzoon Nomanbhoy collaborates with scholars based in United States, United Kingdom and Japan. Tyzoon Nomanbhoy's co-authors include Richard A. Cerione, Nathanael S. Gray, Matthew P. Patricelli, John W. Kozarich, Paul Schimmel, Arwin Aban, Helge Weissig, Qingkai Yang, Jiing‐Dwan Lee and Dario R. Alessi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Tyzoon Nomanbhoy

47 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

2017 402 citations Baishan Jiang, Michael A. Erb et al. Nature Chemical Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tyzoon Nomanbhoy United States	25	2.3k	582	505	449	447	47	3.3k
Xiaoxiang Zhu United States	28	1.8k 0.8×	421 0.7×	693 1.4×	551 1.2×	284 0.6×	48	3.1k
Philip V. LoGrasso United States	38	2.7k 1.1×	458 0.8×	235 0.5×	900 2.0×	332 0.7×	79	4.0k
Hwan Geun Choi South Korea	32	2.8k 1.2×	1.1k 1.9×	125 0.2×	438 1.0×	411 0.9×	77	4.2k
Anna C. Maroney United States	24	1.8k 0.8×	465 0.8×	167 0.3×	219 0.5×	346 0.8×	31	2.6k
Jonathan M. Elkins United Kingdom	30	2.8k 1.2×	672 1.2×	211 0.4×	497 1.1×	533 1.2×	73	4.0k
Timothy W. Corson United States	29	2.7k 1.1×	1.1k 1.9×	166 0.3×	233 0.5×	553 1.2×	95	4.5k
Arianna Donella‐Deana Italy	33	2.2k 0.9×	731 1.3×	129 0.3×	269 0.6×	447 1.0×	91	3.8k
Taebo Sim South Korea	31	3.5k 1.5×	1.1k 1.8×	222 0.4×	951 2.1×	609 1.4×	122	5.2k
Pei‐Jung Lu Taiwan	37	4.0k 1.7×	1.5k 2.5×	205 0.4×	332 0.7×	637 1.4×	100	5.5k
Markus D. Siegelin United States	39	2.7k 1.2×	786 1.4×	142 0.3×	108 0.2×	343 0.8×	109	4.1k

Countries citing papers authored by Tyzoon Nomanbhoy

Since Specialization

Citations

This map shows the geographic impact of Tyzoon Nomanbhoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyzoon Nomanbhoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyzoon Nomanbhoy more than expected).

Fields of papers citing papers by Tyzoon Nomanbhoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyzoon Nomanbhoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyzoon Nomanbhoy. The network helps show where Tyzoon Nomanbhoy may publish in the future.

Co-authorship network of co-authors of Tyzoon Nomanbhoy

This figure shows the co-authorship network connecting the top 25 collaborators of Tyzoon Nomanbhoy. A scholar is included among the top collaborators of Tyzoon Nomanbhoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyzoon Nomanbhoy. Tyzoon Nomanbhoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Johnson, Zoë, Chiara Tarantelli, Luciano Cascione, et al.. (2023). IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer Research Communications. 3(4). 576–591. 10 indexed citations

2.

Roy, Ajit, Arup Chakraborty, Tyzoon Nomanbhoy, & Melvin Depamphilis. (2023). PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells. Autophagy. 19(9). 2464–2484. 8 indexed citations

3.

Jiang, Baishan, Michael A. Erb, Yanke Liang, et al.. (2017). Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

4.

Jiang, Baishan, Michael A. Erb, Yanke Liang, et al.. (2017). Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nature Chemical Biology. 14(2). 163–170. 402 indexed citations breakdown →

5.

Lin, Emme C.K., Christopher M. Amantea, Tyzoon Nomanbhoy, et al.. (2016). ERK5 kinase activity is dispensable for cellular immune response and proliferation. Proceedings of the National Academy of Sciences. 113(42). 11865–11870. 65 indexed citations

6.

Okerberg, Eric, Heidi E. Brown, Arwin Aban, et al.. (2016). Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics. PLoS ONE. 11(3). e0152934–e0152934. 6 indexed citations

7.

Zhang, Tinghu, Francisco Iñesta-Vaquera, Mario Niepel, et al.. (2012). Discovery of Potent and Selective Covalent Inhibitors of JNK. Chemistry & Biology. 19(1). 140–154. 278 indexed citations

8.

Patricelli, Matthew P., Tyzoon Nomanbhoy, Jiangyue Wu, et al.. (2011). In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases. Chemistry & Biology. 18(6). 699–710. 259 indexed citations

9.

Ahn, Kay, Sarah E. Smith, Marya Liimatta, et al.. (2011). Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain. Journal of Pharmacology and Experimental Therapeutics. 338(1). 114–124. 191 indexed citations

10.

Li, Bei, Tyzoon Nomanbhoy, Qiang Li, et al.. (2011). 6-Position optimization of tricyclic 4-quinolone-based inhibitors of glycogen synthase kinase-3β: Discovery of nitrile derivatives with picomolar potency. Bioorganic & Medicinal Chemistry Letters. 22(2). 1005–1008. 7 indexed citations

11.

Li, Bei, Tyzoon Nomanbhoy, Qiang Li, et al.. (2011). Synthesis and structure–activity relationship of 4-quinolone-3-carboxylic acid based inhibitors of glycogen synthase kinase-3β. Bioorganic & Medicinal Chemistry Letters. 21(19). 5948–5951. 20 indexed citations

12.

Johnson, Douglas S., Cory M. Stiff, Scott E. Lazerwith, et al.. (2010). Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Medicinal Chemistry Letters. 2(2). 91–96. 148 indexed citations

13.

Johnson, Douglas S., Kay Ahn, Suzanne R. Kesten, et al.. (2009). Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 19(10). 2865–2869. 59 indexed citations

14.

Ahn, Kyunghye, Douglas S. Johnson, Laura R. Fitzgerald, et al.. (2007). Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity. Biochemistry. 46(45). 13019–13030. 181 indexed citations

15.

Shreder, Kevin, Melissa S. Wong, David T. Winn, et al.. (2005). Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(19). 4256–4260. 12 indexed citations

16.

Hu, Yi, Lifu Ma, Melissa S. Wong, et al.. (2005). Synthesis and structure–activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7. Bioorganic & Medicinal Chemistry Letters. 15(19). 4239–4242. 26 indexed citations

17.

Shreder, Kevin, et al.. (2005). Synthesis of AX7593, a Quinazoline‐Derived Photoaffinity Probe for EGFR.. ChemInform. 36(5). 3 indexed citations

18.

Nomanbhoy, Tyzoon, Jonathan S. Rosenblum, Arwin Aban, & Jonathan J. Burbaum. (2003). Inhibitor Focusing: Direct Selection of Drug Targets from Proteomes Using Activity-Based Probes. Assay and Drug Development Technologies. 1(supplement 2). 137–146. 8 indexed citations

19.

Nomanbhoy, Tyzoon, Jonathan S. Rosenblum, Arwin Aban, & Jonathan J. Burbaum. (2003). Inhibitor Focusing: Direct Selection of Drug Targets from Proteomes Using Activity-Based Probes. Assay and Drug Development Technologies. 1(2). 137–146. 1 indexed citations

20.

Nomanbhoy, Tyzoon, et al.. (1999). Transfer RNA–Dependent Translocation of Misactivated Amino Acids to Prevent Errors in Protein Synthesis. Molecular Cell. 4(4). 519–528. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact